Myriad Genetics, Inc. reported goodwill and long-lived asset impairment charges for the first quarter ended March 31, 2022. For the quarter, the company reported Goodwill and long-lived asset impairment charges of $10.7 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.63 USD | +0.16% | -0.05% | -2.66% |
Mar. 20 | Myriad Genetics Gets US Patent for SneakPeek Snap Device | MT |
Feb. 27 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.66% | 1.68B | |
-11.57% | 7.4B | |
+2.98% | 5.47B | |
+0.98% | 4.51B | |
+5.18% | 4.42B | |
-50.82% | 3.29B | |
+11.23% | 2.66B | |
-16.38% | 2.07B | |
-10.84% | 1.66B | |
-4.35% | 1.46B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics, Inc. Reports Goodwill and Long-Lived Asset Impairment Charges for the First Quarter Ended March 31, 2022